The present invention relates to pharmaceutical compositions and more particularly to a pharmaceutical composition containing (E)-7-4-(4-fluorophenyl)-6-isopropyl-2-methyl(methylsulfonyl)aminopyrimidin-5-yl-(3R, 5S)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically-acceptable salt thereof as the active ingredient and an inorganic salt in which the cation is multivalent.